Article
Nucleocapsid mutation R203K/G204R increases the infectivity, fitness and virulence of…
medRxiv · 2021 · Haibo Wu, author Na Xing, author Kaiwen Meng, author Beibei Fu, author Weiwei Xue, author Pan Dong, author Yang Xiao, author Gexin Liu, author Haitao Luo, author Wenzhuang Zhu, author Xiaoyuan Lin, author Geng Meng, author Zhenglin Zhu, author
Key facts
| Title | Nucleocapsid mutation R203K/G204R increases the infectivity, fitness and virulence of SARS-CoV-2 |
|---|---|
| First author | Haibo Wu, author Na Xing, author Kaiwen Meng, author Beibei Fu, author Weiwei Xue, author Pan Dong, author Yang Xiao, author Gexin Liu, author Haitao Luo, author Wenzhuang Zhu, author Xiaoyuan Lin, author Geng Meng, author Zhenglin Zhu, author |
| Journal | medRxiv |
| Published | May 27, 2021 |
| DOI | 10.1101/2021.05.24.445386 |
| Devices mentioned | 216578, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1